DossierENTITY

avexitide

Coverage of avexitide in the Nexus archive.

Earliest in view: Jul 1 · 08:30 UTCMost recent: Jul 1 · 08:30 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 1 · 08:30 UTCSTAT NEWS
STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watch
STAT’s biotech scorecard for Q3 highlights key events for Amylyx Pharmaceuticals and Biogen. Amylyx will report Phase 3 results for avexitide in post-bariatric hypoglycemia, while Biogen will present detailed data from a mid-stage Alzheimer’s trial for diranersen on July 14.